Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study

T. Scott Stroup, Paul S. Appelbaum, Hongbin Gu, Spencer Hays, Marvin S. Swartz, Richard S.E. Keefe, Scott Y. Kim, Theo C. Manschreck, Roger A. Boshes, Joseph Patrick McEvoy, Jeffrey A. Lieberman

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: Research participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a trial they may not be able to judge and protect their interests. If reduced abilities are common or can be predicted, special protections can be targeted appropriately. Method: We examined longitudinal consent-related abilities of participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study using the MacArthur Competence Assessment Tool-Clinical Research (MacCAT-CR) at protocol-specified times over 18. months. Results: Of 1158 research participants in this analysis, most (n = 650, 56%) had a stable pattern of MacCAT-CR Understanding scores, 235 (20%) improved substantially with no evidence of decline, 273 (24%) had at least one assessment with substantial worsening. During the course of the trial, 43 (4%) fell below the initial threshold for adequate capacity, which was predicted by lower Understanding scores, more severe positive symptoms, and poorer neurocognitive functioning at baseline, and by increases in negative symptoms and deteriorating global status. Conclusions: Most participants in this long-term study had stable or improved consent-related abilities, but almost one-fourth experienced substantial worsening and 4% of participants fell below the study's capacity threshold for enrollment. Clinical investigators should monitor with special care individuals with marginal capacity or higher levels of psychotic symptoms at study entry and those who exhibit clinical worsening during a study.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalSchizophrenia Research
Volume130
Issue number1-3
DOIs
StatePublished - Aug 1 2011

Fingerprint

Aptitude
Antipsychotic Agents
Schizophrenia
Clinical Trials
Research
Mental Competency
Time and Motion Studies
Clinical Protocols
Informed Consent
Longitudinal Studies
Research Personnel

Keywords

  • Decision-making capacity
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Stroup, T. S., Appelbaum, P. S., Gu, H., Hays, S., Swartz, M. S., Keefe, R. S. E., ... Lieberman, J. A. (2011). Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study. Schizophrenia Research, 130(1-3), 47-52. https://doi.org/10.1016/j.schres.2011.04.012

Longitudinal consent-related abilities among research participants with schizophrenia : Results from the CATIE study. / Stroup, T. Scott; Appelbaum, Paul S.; Gu, Hongbin; Hays, Spencer; Swartz, Marvin S.; Keefe, Richard S.E.; Kim, Scott Y.; Manschreck, Theo C.; Boshes, Roger A.; McEvoy, Joseph Patrick; Lieberman, Jeffrey A.

In: Schizophrenia Research, Vol. 130, No. 1-3, 01.08.2011, p. 47-52.

Research output: Contribution to journalArticle

Stroup, TS, Appelbaum, PS, Gu, H, Hays, S, Swartz, MS, Keefe, RSE, Kim, SY, Manschreck, TC, Boshes, RA, McEvoy, JP & Lieberman, JA 2011, 'Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study', Schizophrenia Research, vol. 130, no. 1-3, pp. 47-52. https://doi.org/10.1016/j.schres.2011.04.012
Stroup, T. Scott ; Appelbaum, Paul S. ; Gu, Hongbin ; Hays, Spencer ; Swartz, Marvin S. ; Keefe, Richard S.E. ; Kim, Scott Y. ; Manschreck, Theo C. ; Boshes, Roger A. ; McEvoy, Joseph Patrick ; Lieberman, Jeffrey A. / Longitudinal consent-related abilities among research participants with schizophrenia : Results from the CATIE study. In: Schizophrenia Research. 2011 ; Vol. 130, No. 1-3. pp. 47-52.
@article{4f96561ba8024e98a14b80f7a79cd58b,
title = "Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study",
abstract = "Objective: Research participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a trial they may not be able to judge and protect their interests. If reduced abilities are common or can be predicted, special protections can be targeted appropriately. Method: We examined longitudinal consent-related abilities of participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study using the MacArthur Competence Assessment Tool-Clinical Research (MacCAT-CR) at protocol-specified times over 18. months. Results: Of 1158 research participants in this analysis, most (n = 650, 56{\%}) had a stable pattern of MacCAT-CR Understanding scores, 235 (20{\%}) improved substantially with no evidence of decline, 273 (24{\%}) had at least one assessment with substantial worsening. During the course of the trial, 43 (4{\%}) fell below the initial threshold for adequate capacity, which was predicted by lower Understanding scores, more severe positive symptoms, and poorer neurocognitive functioning at baseline, and by increases in negative symptoms and deteriorating global status. Conclusions: Most participants in this long-term study had stable or improved consent-related abilities, but almost one-fourth experienced substantial worsening and 4{\%} of participants fell below the study's capacity threshold for enrollment. Clinical investigators should monitor with special care individuals with marginal capacity or higher levels of psychotic symptoms at study entry and those who exhibit clinical worsening during a study.",
keywords = "Decision-making capacity, Schizophrenia",
author = "Stroup, {T. Scott} and Appelbaum, {Paul S.} and Hongbin Gu and Spencer Hays and Swartz, {Marvin S.} and Keefe, {Richard S.E.} and Kim, {Scott Y.} and Manschreck, {Theo C.} and Boshes, {Roger A.} and McEvoy, {Joseph Patrick} and Lieberman, {Jeffrey A.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1016/j.schres.2011.04.012",
language = "English (US)",
volume = "130",
pages = "47--52",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Longitudinal consent-related abilities among research participants with schizophrenia

T2 - Results from the CATIE study

AU - Stroup, T. Scott

AU - Appelbaum, Paul S.

AU - Gu, Hongbin

AU - Hays, Spencer

AU - Swartz, Marvin S.

AU - Keefe, Richard S.E.

AU - Kim, Scott Y.

AU - Manschreck, Theo C.

AU - Boshes, Roger A.

AU - McEvoy, Joseph Patrick

AU - Lieberman, Jeffrey A.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Objective: Research participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a trial they may not be able to judge and protect their interests. If reduced abilities are common or can be predicted, special protections can be targeted appropriately. Method: We examined longitudinal consent-related abilities of participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study using the MacArthur Competence Assessment Tool-Clinical Research (MacCAT-CR) at protocol-specified times over 18. months. Results: Of 1158 research participants in this analysis, most (n = 650, 56%) had a stable pattern of MacCAT-CR Understanding scores, 235 (20%) improved substantially with no evidence of decline, 273 (24%) had at least one assessment with substantial worsening. During the course of the trial, 43 (4%) fell below the initial threshold for adequate capacity, which was predicted by lower Understanding scores, more severe positive symptoms, and poorer neurocognitive functioning at baseline, and by increases in negative symptoms and deteriorating global status. Conclusions: Most participants in this long-term study had stable or improved consent-related abilities, but almost one-fourth experienced substantial worsening and 4% of participants fell below the study's capacity threshold for enrollment. Clinical investigators should monitor with special care individuals with marginal capacity or higher levels of psychotic symptoms at study entry and those who exhibit clinical worsening during a study.

AB - Objective: Research participants must have adequate consent-related abilities to provide informed consent at the time of study enrollment. We sought to determine if research participants with schizophrenia maintain adequate consent-related abilities during a longitudinal study. If participants lose abilities during a trial they may not be able to judge and protect their interests. If reduced abilities are common or can be predicted, special protections can be targeted appropriately. Method: We examined longitudinal consent-related abilities of participants in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study using the MacArthur Competence Assessment Tool-Clinical Research (MacCAT-CR) at protocol-specified times over 18. months. Results: Of 1158 research participants in this analysis, most (n = 650, 56%) had a stable pattern of MacCAT-CR Understanding scores, 235 (20%) improved substantially with no evidence of decline, 273 (24%) had at least one assessment with substantial worsening. During the course of the trial, 43 (4%) fell below the initial threshold for adequate capacity, which was predicted by lower Understanding scores, more severe positive symptoms, and poorer neurocognitive functioning at baseline, and by increases in negative symptoms and deteriorating global status. Conclusions: Most participants in this long-term study had stable or improved consent-related abilities, but almost one-fourth experienced substantial worsening and 4% of participants fell below the study's capacity threshold for enrollment. Clinical investigators should monitor with special care individuals with marginal capacity or higher levels of psychotic symptoms at study entry and those who exhibit clinical worsening during a study.

KW - Decision-making capacity

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=79960315812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960315812&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2011.04.012

DO - 10.1016/j.schres.2011.04.012

M3 - Article

C2 - 21561740

AN - SCOPUS:79960315812

VL - 130

SP - 47

EP - 52

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 1-3

ER -